Examination of the Expression Levels of MACC1, Filamin A and FBXW7 Genes in Colorectal Cancer Patients

Overview

Journal North Clin Istanb

Publisher Kare Publishing

Specialty General Medicine

Date 2020 Apr 2

PMID 32232196

Citations 1

Authors

Funda Yesilkaya

Didem Tastekin

Hani Al Saadoni

Arzu Ergen

Sadrettin Pence

Affiliations

Soon will be listed here.

Abstract

Objective: Colorectal cancer (CRC) is the third most common type of cancer observed in cancer-related mortality because it has a high metastasis ratio. This study aims to investigate the expression levels of several genes, including metastasis-related colon cancer 1 (MACC1), Filamin A (FLNA), F-box/WD repeat-containing protein 7 (FBXW7), which has an important role in cell signaling, migration and adhesion through the remodeling of the cell skeleton.

Methods: In this study, 21 patients with a precise diagnosis of CRC and 21 controls were included. Gene expressions were examined using the RT-PCR technique. To define the relationship of the genes with metastasis, blood samples were collected from all patients with colon/rectal cancer diagnosis without metastasis at six months before and after the medication with Xelox.

Results: Our findings showed that no significant difference was observed in the pre-treatment values compared to the control group, whereas FLNA (p=0.001) expression was observed to be significantly increased following treatment with Xelox.

Conclusion: To our knowledge, our study is the first study to investigate the effects of Xelox treatment on the expression levels of MACC1, FBXW7 and FLNA genes in non-metastatic colorectal cancer patients in Turkey.

Citing Articles

Cancer as a biophysical disease: Targeting the mechanical-adaptability program.

Nguyen L, Jacob M, Parajon E, Robinson D Biophys J. 2022; 121(19):3573-3585.

PMID: 35505610 PMC: 9617128. DOI: 10.1016/j.bpj.2022.04.039.

References

Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I . MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2008; 15(1):59-67. DOI: 10.1038/nm.1889. View

Wertz I, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson D . Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature. 2011; 471(7336):110-4. DOI: 10.1038/nature09779. View

Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y . Colorectal cancer: genetics of development and metastasis. J Gastroenterol. 2006; 41(3):185-92. DOI: 10.1007/s00535-006-1801-6. View

Al-Sohaily S, Biankin A, Leong R, Kohonen-Corish M, Warusavitarne J . Molecular pathways in colorectal cancer. J Gastroenterol Hepatol. 2012; 27(9):1423-31. DOI: 10.1111/j.1440-1746.2012.07200.x. View

Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke K . Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS One. 2012; 7(11):e49249. PMC: 3498161. DOI: 10.1371/journal.pone.0049249. View

Schmid F, Wang Q, Huska M, Andrade-Navarro M, Lemm M, Fichtner I . SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival. Oncogene. 2015; 35(46):5942-5952. DOI: 10.1038/onc.2015.451. View

Zhang Y, Wang Z, Chen M, Peng L, Wang X, Ma Q . MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer. 2012; 11:23. PMC: 3351020. DOI: 10.1186/1476-4598-11-23. View

Tian Z, Shi J, Wang X, Li Z, Wang G . New cancer suppressor gene for colorectal adenocarcinoma: filamin A. World J Gastroenterol. 2015; 21(7):2199-205. PMC: 4326159. DOI: 10.3748/wjg.v21.i7.2199. View

Galimi F, Torti D, Sassi F, Isella C, Cora D, Gastaldi S . Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations. Clin Cancer Res. 2011; 17(10):3146-56. DOI: 10.1158/1078-0432.CCR-10-3377. View

10.

Shirahata A, Shinmura K, Kitamura Y, Sakuraba K, Yokomizo K, Goto T . MACC1 as a marker for advanced colorectal carcinoma. Anticancer Res. 2010; 30(7):2689-92. View

11.

Rodriguez-Bigas M, Stoler D, Bertario L, Anderson G, Baba S . Colorectal cancer: how does it start? How does it metastasize?. Surg Oncol Clin N Am. 2000; 9(4):643-52; discussion 653-4. View

12.

Babaei-Jadidi R, Li N, Saadeddin A, Spencer-Dene B, Jandke A, Muhammad B . FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation. J Exp Med. 2011; 208(2):295-312. PMC: 3039859. DOI: 10.1084/jem.20100830. View

13.

Yue J, Huhn S, Shen Z . Complex roles of filamin-A mediated cytoskeleton network in cancer progression. Cell Biosci. 2013; 3(1):7. PMC: 3573937. DOI: 10.1186/2045-3701-3-7. View

14.

Stein U, Smith J, Walther W, Arlt F . MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle. 2009; 8(15):2467-9. DOI: 10.4161/cc.8.15.9018. View

15.

Jeon T, Esquejo R, Roqueta-Rivera M, Phelan P, Moon Y, Govindarajan S . An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis. Cell Metab. 2013; 18(1):51-61. PMC: 3740797. DOI: 10.1016/j.cmet.2013.06.010. View

16.

Zhou A, Hartwig J, Akyurek L . Filamins in cell signaling, transcription and organ development. Trends Cell Biol. 2010; 20(2):113-23. DOI: 10.1016/j.tcb.2009.12.001. View

17.

Arabi A, Ullah K, Branca R, Johansson J, Bandarra D, Haneklaus M . Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway. Nat Commun. 2012; 3:976. PMC: 4354031. DOI: 10.1038/ncomms1975. View

18.

Wang Z, Inuzuka H, Zhong J, Wan L, Fukushima H, Sarkar F . Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Lett. 2012; 586(10):1409-18. PMC: 3372850. DOI: 10.1016/j.febslet.2012.03.017. View

19.

Wang Z, Inuzuka H, Fukushima H, Wan L, Gao D, Shaik S . Emerging roles of the FBW7 tumour suppressor in stem cell differentiation. EMBO Rep. 2011; 13(1):36-43. PMC: 3246256. DOI: 10.1038/embor.2011.231. View

20.

Haraldsdottir S, Einarsdottir H, Smaradottir A, Gunnlaugsson A, Halfdanarson T . [Colorectal cancer - review]. Laeknabladid. 2014; 100(2):75-82. DOI: 10.17992/lbl.2014.02.531. View